Intercell AG (JOBS) Eyes FY Loss on Weak Vaccine Sales
11/9/2009 7:38:54 AM
More...
|
US Panel Backs New Intercell AG Encephalitis Vaccine
6/25/2009 6:45:54 AM
More...
|
Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention
5/29/2009 10:40:26 AM
More...
|
Intercell AG Executes Multi-Year Contract for Supply of IXIARO(R) to the United States Military
5/11/2009 11:18:45 AM
More...
|
Intercell AG Starts a Phase I Clinical Trial for a New Streptococcus pneumoniae Vaccine
4/8/2009 9:14:36 AM
More...
|
Intercell AG Starts a Phase I Clinical Trial For A New Streptococcus Pneumoniae Vaccine
4/7/2009 12:31:54 PM
More...
|
Intercell AG Announces European Approval Of New Vaccine, IXIARO(R), To Prevent Japanese Encephalitis
4/3/2009 8:33:47 AM
More...
|
Intercell AG to Host Conference Call and Webcast Today on FDA Approval of IXIARO(R) Japanese Encephalitis Vaccine
3/31/2009 8:26:58 AM
More...
|
Intercell AG Announces FDA Approval of IXIARO(R), a Novel Vaccine to Prevent Japanese Encephalitis
3/30/2009 9:53:39 PM
More...
|
Australian Authorities (TGA) First to Grant Final Product Approval for Intercell AG's Vaccine to Prevent Japanese Encephalitis
1/23/2009 8:58:24 AM
More...
|
|